+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Disease%20and%20Therapy%20Review%3A%20Multiple%20Sclerosis

Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Product Thumbnail Image

Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders

  • Report
  • September 2023
  • 180 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 898 Pages
  • Global
From
Autoinjectors - Global Strategic Business Report - Product Thumbnail Image

Autoinjectors - Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Myelin Regeneration in Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Myelin Regeneration in Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • June 2023
  • 200 Pages
  • Global
From
Aptamers: Therapeutics, Technologies and Services Market, Distribution by Application Area, Type of Aptamer, Target Indication, Route of Administration, Scale of Operation, Focus Area, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Aptamers: Therapeutics, Technologies and Services Market, Distribution by Application Area, Type of Aptamer, Target Indication, Route of Administration, Scale of Operation, Focus Area, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • April 2022
  • 350 Pages
  • Global
From
Global Autoinjectors Market by Type of Autoinjector, Route of Administration, Type of Molecule, Therapeutic Indication and Geography: Industry Trends and Global Forecasts, 2021-2035 - Product Thumbnail Image

Global Autoinjectors Market by Type of Autoinjector, Route of Administration, Type of Molecule, Therapeutic Indication and Geography: Industry Trends and Global Forecasts, 2021-2035

  • Report
  • November 2021
  • 610 Pages
  • Global
From
Global Markets for Orphan Drugs - Product Thumbnail Image

Global Markets for Orphan Drugs

  • Report
  • January 2024
  • 189 Pages
  • Global
From
Antibody Drugs: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets 2021-2026

  • Report
  • October 2021
  • 133 Pages
  • Global
From
Neurorehabilitation Devices - Global Strategic Business Report - Product Thumbnail Image

Neurorehabilitation Devices - Global Strategic Business Report

  • Report
  • April 2024
  • 504 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Relapsing Multiple Sclerosis (RMS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Progressive Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Progressive Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Thumbnail Image

Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • April 2023
  • 117 Pages
  • Global
From
Primary Progressive Multiple Sclerosis (PPMS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Primary Progressive Multiple Sclerosis (PPMS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Secondary Progressive Multiple Sclerosis (SPMS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Secondary Progressive Multiple Sclerosis (SPMS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 276 Pages
  • Global
From
Neuromodulation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Neuromodulation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 115 Pages
  • Global
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 138 Pages
  • Global
From
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 151 Pages
  • Global
From
Loading Indicator